Pluss Polymers secures 4th position at India Innovation Growth Programme (IIGP) 2015 by FICCI
New Delhi : - PLUSS Polymers, the leader in research, development and manufacturing of specialty ...
New Delhi : - PLUSS Polymers, the leader in research, development and manufacturing of specialty polymers and Phase Change Materials (PCMs), has been recognized by FICCI for its leading-edge medical technology; MiraCradle- Neonate Cooler. It has secured the 4th rank among top 30 Innovations at the �India Innovation Growth Programme (IIGP) 2015� Samit Jain, Managing Director, Pluss Polymers commented on the occasion, �This recognition inspires us to thrust ourselves further and make this technology available in every nook and corner of the country and reduce neonatal deaths. It motivates us to strive towards bringing in revolutionary technologies in various fields and put PLUSS on the global innovation map of creating impactful innovations. The top three technologies that secured the 1st, 2nd and 3rd positions at the IIGP 2015 are XrayTo3D software to make 3D images out of x-rays, Tabplan3D- A novel preventive technique to help patients manage kidney disease and Dance Aid for Deaf respectively. During the first phase of the programme, a project team comprising of subject matter experts from FICCI selected 100 innovative technologies out of over 1300 entries in a wide range of sectors such as aeronautics, agriculture, biotechnology, chemistry, communications, computing, defense, electronics, environment, healthcare, information technology, manufacturing, materials, life sciences, nanotechnology, petrochemical, semiconductors and transportation. FICCI approved applications and technologies were evaluated and ranked by the joint team comprising all programme partners. Pre-defined parameters such as development status, patent status, funding required to technology development, etc. were used to select the most appropriate technology companies to go forward in the programme. The assessment was done in two phases. During the first phase, evaluators reviewed and gave constructive feedback on the technical and commercialization potential of the application submissions. In the second phase, refined applications were scored based on predefined parameters and evaluator feedback to select the top 50. These top 50 innovators were given advanced training and at the end of the competition, 30 best innovations were awarded. The India Innovation Growth Programme is a joint initiative of the Department of Science and Technology, Govt. Of India, Lockheed Martin Corporation; Indo-US Science and Technology Forum, Federation of Indian Chambers of Commerce and Industry (FICCI); Stanford Graduate School of Business and the IC2 Institute at the University of Texas. The aim of this programme is to accelerate innovative Indian technologies into the global markets. The India Innovation Growth Program is the only program of its kind, because of its focus on teaching using world-class commercialization strategies and the business development assistance provided. MiraCradle is an affordable treatment for Neonatal Asphyxia and will help India and the world get one step closer to the MDG 2015 goal. The product has been applauded in the past at the Kirloskar Technologies Awards in Chandigarh for Excellence and Innovation in Medical Devices and �Best Innovation & Research in Health Care� at the Indo-Global Healthcare Summit & Expo 2014.
All Right Reserved